BUSINESS
Hindalco reports strong earnings growth in Q4
Aluminum prices are seeing an upward trend because of the tightness in global supply and US and UK sanctions on Russia
BUSINESS
PI Industries: New products, pharma to define medium-term growth
PI has guided to a 15 percent top-line growth and 24-25 percent EBITDA margin in FY25
BUSINESS
Rainbow: Q4 FY24 weaker than expected; ramp-up of new hospitals is key
The company is best-placed to benefit from the synergies between paediatric and OB-GYN segments
BUSINESS
JSW Steel ends FY24 on a mixed note — top line grows, net profit tumbles
A lot of drivers are in place for an improved performance in FY25
BUSINESS
UPL: Growth outlook uninspiring; leverage continues to hurt
Working capital management and debt reduction will be key factors to watch
BUSINESS
Jindal Steel and Power: Well-placed for FY25
JSPL is focusing on higher-margin products and aggressively working towards capacity expansion
BUSINESS
Vijaya Diagnostic Centre: Sustaining strong margin profile
Prudent strategies are in place to expand in the eastern and western regions of the country.
BUSINESS
Hindalco Q4: Strong operating performance by Novelis
India aluminium business will see lower cost on the back of captive alumina and better captive coal linkages
BUSINESS
Coal India Q4FY24: Long-term growth remains intact
E-auction premiums have normalised. Price hikes in the FSA segment are keenly awaited by the Street
BUSINESS
Apollo Hospitals’ pharmacy business moves to the right track
The company achieved EBITDA breakeven in AHL, its pharma business, one quarter earlier than estimated
BUSINESS
Coromandel International: Weak Q4, new businesses yet to make a mark
Subsidy rates for the 2024 Kharif cropping season will be the key factor to watch
BUSINESS
Rallis India finishes Q4 FY24 on a weak note
The company could lag industry growth in FY25 as the export market remains muted
BUSINESS
What should you do with Max Healthcare’s stock?
Near-term outlook should support the stock momentum; however, valuations stand elevated
BUSINESS
Why are we equal-weight on these two fertiliser stocks?
While the long-term business growth strategy remains promising, the near-term environment remains quite challenging
BUSINESS
Growth momentum intact at PI Industries
PI’s business remains shielded from the sensitivities attached to the agrochemical business
BUSINESS
Discovery Series | Rainbow: Can this niche play on healthcare shape up your portfolio?
Huge room to benefit from the synergies between paediatric and maternity care services
BUSINESS
Krsnaa Diagnostics presents a reasonable risk-reward opportunity
The business has ample room for expansion and the ongoing revenue growth trend should continue into the next fiscal year
BUSINESS
Dhanuka Agritech: Why it presents a buying opportunity
Given the indication of a normal monsoon this year, the domestic agrochemical market is poised to do well
BUSINESS
R K Swamy IPO: Should you get creative with your portfolio?
Marketing agencies have gained significant importance in today’s world and there is huge growth opportunity for this industry
BUSINESS
Vijaya Diagnostic Centre: Traction in new hubs adds to confidence
Focused on replicating its home market success in the eastern and western regions of the country.
BUSINESS
Hindalco: Listing of Novelis in the offing
Novelis generates 60 percent of EBITDA for Hindalco. It will not receive any proceeds from the sale of shares by its shareholders
BUSINESS
NMDC notches up stellar numbers in December quarter
Production, sales volume came in higher while iron ore realisation was 13 percent more
BUSINESS
Hindalco: Why are we downgrading the stock to equal-weight?
India Aluminium business will see lower cost on the back of captive alumina and better captive coal linkages
BUSINESS
Coal India: Higher volumes, e-auction prices support higher Q3 earnings
Price hikes in the FSA segment are keenly awaited by the Street
